Dissociable nano-particles based on curcumin iron coordination as well as preparation method and application of dissociable nano-particles

By using curcumin/polyethylene glycol grafted polyglutamate/iron-coordinated nanoparticles in photothermal therapy, combined with EPR effect and dynamic deassembly technology, the uneven distribution and removal of nanoparticles in photothermal therapy are solved. The difficult problem has achieved efficient tumor treatment and reduced toxicity.

CN119015259APending Publication Date: 2024-11-26JILIN TEACHERS INST OF ENG & TECH
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411143593.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

In existing photothermal treatments, nanoparticles are unevenly distributed in the tumor site and are difficult to quickly remove, resulting in uneven heat distribution and potential toxicity.

Method used

Dissociable nanoparticles based on curcumin/polyethylene glycol grafting are accumulated at the tumor site through the EPR effect and triggered by deferroamine methanesulfonate after completion of photothermal function. Unassemble, release curcumin to enhance therapeutic effects and accelerate renal clearance.

Benefits of technology

The effective accumulation and rapid removal of nanoparticles in the tumor site is achieved, the effect of photothermal treatment is improved, and the potential toxicity to the body is reduced.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015259A_ABST
    Figure CN119015259A_ABST
Patent Text Reader

Abstract

The invention discloses dissociable nanoparticles based on curcumin iron coordination and a preparation method and application thereof, and belongs to the technical field of photothermal conversion materials. The preparation method of the dissociable nano-particles based on curcumin iron coordination comprises the following steps: uniformly mixing soluble iron salt, polyethylene glycol grafted polyglutamic acid and water, then adding a curcumin ethanol solution, and then carrying out stirring, impurity removal, centrifugation and ultrasonic treatment to prepare the dissociable nano-particles based on curcumin iron coordination. An endogenous iron element, food-borne curcumin and polymers polyethylene glycol and polyglutamic acid approved by FDA are selected as raw materials, and the constructed curcumin iron coordination-based dissociable nanoparticles have an appropriate EPR effect, can be accumulated in a tumor area and can be used for efficient photo-thermal therapy. Moreover, after the treatment work is finished, dissociation can be carried out through a dynamic disassembly strategy triggered by deferoxamine mesylate, curcumin is released so as to realize photothermal therapy and chemotherapy combined therapy and realize rapid removal, so that potential long-term toxicity to main visceral organs is avoided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of photothermal conversion materials, and in particular relates to a dissociable nanoparticle based on curcumin iron coordination, and a preparation method and application thereof. Background Art

[0002] Photothermal therapy (PTT) is an emerging and highly effective tumor treatment method with the advantages of specific selectivity and minimal invasiveness. However, due to the heterogeneity of tumors, the heat generated during laser irradiation is unevenly distributed in the tumor, and it is difficult to achieve complete tumor ablation with a single photothermal therapy. In recent years, studies have shown that the combination strategy of photothermal therapy and chemotherapy is an effective method to improve the anti-tumor effect. In addition, although large-sized nanoparticles with EPR effect have good anti-tumor effects, they are easily captured by reticuloendothelial tissues (such as liver, spleen, etc.), resulting in their long-term retention in the body, which in turn causes potential toxicity to the body. Small-sized nanoparticles (<6nm) can be quickly excreted from the body through renal clearance, but their poor EPR effect limits their further application in the body. At present, few works report how to solve the dilemma of effective accumulation in tumor sites and rapid renal clearance. Summary of the invention

[0003] The object of the present invention is to provide a dissociable nanoparticle based on curcumin iron coordination and a preparation method and application thereof. Dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination have a long in vivo circulation time, can effectively accumulate at the tumor site through the EPR effect, and exert good photothermal performance. More importantly, after completing the photothermal function, the dynamic disassembly triggered by deferoxamine mesylate (DFO) can, on the one hand, enhance the photothermal therapeutic effect by releasing curcumin; on the other hand, accelerate the clearance process in the body through renal clearance, and alleviate the potential harm to the body. This kind of photothermal nanoparticles with DFO-triggered disassembly performance have great application prospects in the biomedical field.

[0004] To achieve the above object, the present invention provides the following technical solutions:

[0005] One of the technical solutions of the present invention is to provide a method for preparing dissociable nanoparticles based on curcumin iron coordination, comprising the following steps:

[0006] The soluble iron salt, polyethylene glycol-grafted polyglutamic acid (PLG-g-mPEG) and water are evenly mixed, and then a curcumin ethanol solution is added. After stirring, impurity removal, centrifugation and ultrasound, dissociable nanoparticles based on curcumin iron coordination are prepared.

[0007] Preferably, the soluble iron salt is ferric chloride.

[0008] Preferably, the preparation steps of the polyethylene glycol grafted polyglutamic acid include: first, preparing poly-L-glutamic acid by ring-opening polymerization of BLG-NCA and then removing benzyl protection, and then preparing polyethylene glycol grafted polyglutamic acid by Steglich esterification reaction of poly-L-glutamic acid and polyethylene glycol monomethyl ether; wherein the molecular weight of polyethylene glycol monomethyl ether is 1000-10000Da, the molecular weight of poly-L-glutamic acid is 10000-50000Da, and the mass ratio of polyethylene glycol monomethyl ether to poly-L-glutamic acid is (1-10):1.

[0009] More preferably, the molecular weight of the polyethylene glycol monomethyl ether used is 5000 Da, the molecular weight of the poly-L-glutamic acid is 23000 Da, and the mass ratio of polyethylene glycol monomethyl ether to poly-L-glutamic acid is 2:1.

[0010] Preferably, the usage ratio of the soluble iron salt, the polyethylene glycol-grafted polyglutamic acid and the curcumin is 1.48 mmol:457.6 mg:200 mg.

[0011] Preferably, the concentration of the curcumin ethanol solution is 10 mg mL -1 The curcumin ethanol solution was added dropwise at a rate of 0.5 to 1 mL min -1 .

[0012] Preferably, the stirring time is 4 to 24 hours; the impurity removal method is dialysis; the centrifugal speed is 6000 to 10000 rpm; and the ultrasonic time is 5 to 30 minutes.

[0013] More preferably, the stirring time is 12 h; the centrifugal speed is 8000 rpm; and the ultrasonic time is 10 min.

[0014] The second technical solution of the present invention is to provide a curcumin-iron coordinated dissociable nanoparticle prepared according to the preparation method of the curcumin-iron coordinated dissociable nanoparticle.

[0015] The third technical solution of the present invention is to provide an application of the above-mentioned dissociable nanoparticles based on curcumin iron coordination in the preparation of photothermal therapy drugs.

[0016] The fourth technical solution of the present invention is to provide a method for dissociating the above-mentioned dissociable nanoparticles based on curcumin iron coordination, wherein the substance used for dissociation is deferoxamine mesylate.

[0017] The dissociation substance deferoxamine mesylate added in the present invention can quickly dissociate the dissociable nanoparticles based on curcumin iron coordination into small nanoparticles or small molecule solutions, quickly remove the polymer nanoparticles in the liver, and reduce potential damage to the liver.

[0018] The fifth technical solution of the present invention: provides an application of the above-mentioned dissociable nanoparticles based on curcumin iron coordination and deferoxamine mesylate in the preparation of a combined photothermal therapy and chemotherapy drug.

[0019] The beneficial technical effects of the present invention are as follows:

[0020] The present invention uses endogenous iron, food-derived curcumin, and FDA-approved polymers polyethylene glycol and polyglutamic acid as raw materials to construct multifunctional curcumin-iron-coordinated dissociable nanoparticles (curcumin / polyethylene glycol-grafted polyglutamic acid / iron-coordinated dissociable nanoparticles) with good photothermal performance and safety, solving the dilemma of effective accumulation of photothermal nanoparticles in tumor sites and rapid renal clearance.

[0021] The preparation steps provided by the present invention are simple, the conditions are mild, the operation is easy, the raw materials are of low or non-toxic and low price, etc. The prepared coordination polymer nanoparticles have long circulation function; the particle size range is between 120 and 130 nm, with a suitable EPR effect, accumulation in the tumor area, and efficient photothermal therapy can be performed. Moreover, after the treatment is completed, the dynamic disassembly strategy triggered by deferoxamine mesylate can be used to dissociate, release curcumin to achieve photothermal therapy and chemotherapy combined treatment, and achieve rapid clearance, thereby avoiding potential long-term toxicity to major organs. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 A to D are the particle size, TEM image, potential and XRD pattern of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination in Example 1; E is the particle size, TEM image, potential and XRD pattern of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid (PLG-g-mPEG) and PLG-g-mPEG+Fe Ⅲ Fourier transform infrared spectrum; F is the stability of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination at different times in Example 1; G is a photograph of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination after adding different concentrations of DFO in Example 1.

[0023] Figure 2 A is the temperature change curve of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination in Example 1 after irradiation with 808 nm laser of different powers; B is the temperature change curve of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination in Example 1 after 808 nm laser irradiation (1 W·cm -1, 5min); C is the survival rate of 4T1 cells co-cultured with curcumin / polyethylene glycol-grafted polyglutamic acid / iron-coordinated dissociable nanoparticles solution of different concentrations for 24h; D is the survival rate of 4T1 cells co-cultured with curcumin / polyethylene glycol-grafted polyglutamic acid / iron-coordinated dissociable nanoparticles solution of different concentrations after 808nm laser irradiation (1W·cm -1 , 5min) after 4T1 cells were co-cultured with different concentrations of curcumin / polyethylene glycol-grafted polyglutamic acid / iron-coordinated dissociable nanoparticle solutions and irradiated with 808nm laser (1W·cm -1 , 5min) after live / dead cell staining; F is the biodistribution results of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination in Example 1 at different time points after tail vein injection; G is the biodistribution results of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination in Example 1 injected into tumor-bearing mice 24h after being illuminated by 808nm laser (1W·cm -1 ,5min) thermal imaging after irradiation.

[0024] Figure 3 A in the middle is a time flow chart of DFO-triggered dynamic assembly for enhancing the effect of photothermal therapy; BF are the time-varying curves of tumor volume, tumor photos, tumor weight, body weight change curves of mice after different treatments, and H&E staining images of tumor sections.

[0025] Figure 4 This is an H&E staining image of the heart, liver, spleen, lung and kidney of mice after treatment with the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination in Example 1.

[0026] Figure 5 A is a schematic diagram of detecting the iron content in the liver, kidney, feces and urine of mice after injection of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination in Example 1; BC is the change of the iron content in the liver and kidney of mice after injection of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination in Example 1 with or without DFO treatment; DE is the change of the iron content in the feces and urine of mice after injection of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination in Example 1 with or without DFO treatment. DETAILED DESCRIPTION

[0027] Now, various exemplary embodiments of the present invention are described in detail, and this detailed description should not be considered as a limitation of the present invention, but should be understood as a more detailed description of certain aspects, characteristics and embodiments of the present invention. It should be understood that the terms described in the present invention are only for describing specific embodiments and are not used to limit the present invention.

[0028] In addition, for the numerical range in the present invention, it is understood that each intermediate value between the upper and lower limits of the range is also specifically disclosed. The intermediate value in any stated value or stated range, and each smaller range between any other stated value or intermediate value in the range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.

[0029] Unless otherwise specified, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which the invention pertains. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein may also be used in the practice or testing of the present invention.

[0030] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.

[0031] Unless otherwise specified, the room temperature in the present invention is 25±2°C.

[0032] Example 1

[0033] Preparation of poly-L-glutamic acid (PLG): Weigh BLG-NCA (30.0 g, 114 mmol) in a reaction bottle, add anhydrous DMF (10 mL / g BLG-NCA) under nitrogen to completely dissolve the solid, and then add n-hexylamine initiator (72.1 mg, 0.713 mmol). After reacting at room temperature for 3 days, precipitate in ether, filter, and vacuum dry to obtain polybenzyl glutamic acid (PBLG). Weigh 20.0 g of PBLG, completely dissolve in 200 mL of DCA, 80 mL of acetic acid solution of hydrogen bromide (33 wt%), seal at 30 ° C for 1 hour, precipitate in ether and vacuum dry, redissolve in DMF and dialyze, and freeze-dry to obtain poly-L-glutamic acid (molecular weight 23000).

[0034] Preparation of polyethylene glycol grafted polyglutamic acid (PLG-g-mPEG): weigh 1.01 g PLG, 2.02 g dry mPEG 5Kand DMAP (49.4 mg, 0.404 mmol) in a reaction bottle, add anhydrous DMF (30 mL) to completely dissolve the solid after vacuum ventilation, then add DIC (0.506 g, 4.00 mmol), stir at room temperature for 3 days, precipitate in ether, filter, vacuum dry, then dissolve in DMF, dialysis purification (molecular weight cutoff is 3500 Da), and freeze-dry to obtain the product PLG-g-mPEG.

[0035] Preparation of curcumin / PEG-grafted polyglutamic acid / iron-coordinated dissociable nanoparticles (FeCNPs): 400 mg of FeCl3·6H2O was dissolved in 4 mL of ultrapure water to obtain a FeCl3·6H2O aqueous solution; this solution was then added dropwise to a stirred PLG-g-mPEG aqueous solution (2.6 mg mL -1 , 176 mL), stirred at room temperature for 1 h, and then heated at 0.5 mL min -1 20 mL of anhydrous ethanol was added with a dropwise rate of 100 μg / mL -1 ), stirred at room temperature for 12 h. Finally, the solution was dialyzed (molecular weight cut-off of 3500 Da) to remove components that did not participate in the formation of nanoparticles, centrifuged at 8000 rpm for 10 min, and ultrasonicated for 10 min to obtain a dissociable nanoparticle solution based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination.

[0036] Figure 1 A to D are the particle size, TEM image, potential and XRD pattern of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination in Example 1; E is the particle size, TEM image, potential and XRD pattern of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid (PLG-g-mPEG) and PLG-g-mPEG+Fe Ⅲ Fourier transform infrared spectrum; F is the stability of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination at different times in Example 1; G is a photograph of the dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination after adding different concentrations of DFO in Example 1.

[0037] The particle size was measured by nanometer particle size potential analyzer and was about 125nm ( Figure 1 A). The dissociable nanoparticles based on curcumin / polyethylene glycol grafted polyglutamic acid / iron coordination prepared in Example 1 were analyzed by transmission electron microscopy. The results showed that the nanoparticles had similar sizes ( Figure 1 The Zeta potential of the nanoparticles is -13.6 mV ( Figure 1 C), which will facilitate its circulation in the body. The X-ray diffraction (XRD) spectrum shows that the coordination polymer nanoparticles prepared in the embodiment are amorphous materials ( Figure 1 D). Figure 1 As shown in Figure E, compared with the infrared spectrum of PLG-g-mPEG, PLG-g-mPEG+Fe III (Prepared by stirring PLG-g-mPEG solution with FeCl3·6H2O solution) In the infrared spectrum, 1593 cm -1 The characteristic peak at 4°C proved the existence of COO-Fe. After the prepared nanoparticle solution was placed at 4°C for 90 days, no precipitation was produced, indicating that it has a high degree of stability ( Figure 1 F). Subsequently, we investigated whether DFO could trigger the dynamic disassembly of nanoparticles. Figure 1 As shown in G, nanoparticle solutions were added with different concentrations (0, 25, 50, 100 μg mL -1 )DFO after 30min, a significant color change occurred.

[0038] The performance test of the curcumin / polyethylene glycol grafted polyglutamic acid / iron coordinated dissociable nanoparticle solution (referred to as nanoparticle aqueous solution) prepared in Example 1 was carried out:

[0039] 1. Evaluation of in vitro photothermal performance:

[0040] The prepared nanoparticle solution (0.5 mg mL -1 ) was irradiated for 10 min, the temperature change every 10 s during the process was recorded by a thermal imager, and a curve of temperature change over time was drawn.

[0041] like Figure 2 As shown in Figure A, the temperature increases significantly with the increase of laser intensity. -2 After 10 min of laser irradiation, 0.5 mg mL -1 The temperature of the nanoparticle solution increased from 25°C to 54°C ( Figure 2 (B) The results show that the nanoparticles have good near-infrared photothermal effect.

[0042] 2. Extracorporeal photothermal therapy:

[0043] 4T1 cell line was selected for in vitro photothermal therapy. Cells were plated at 1×10 4 The cells were seeded in a 96-well plate at a density of 1.50 μg / cm2 and cultured overnight. Different concentrations of polymer nanoparticles were added to the cells and irradiated with a laser (808 nm) after 4 h of culture.

[0044] Laser irradiation (808 nm) with a laser power of 1 W cm -2; The irradiation time was 5 min. After irradiation, the cells were cultured for 24 h and 20 μL of thiazolyl blue solution (5 mg mL -1 ), continue to culture for 4 hours, add dimethyl sulfoxide to dissolve, and measure the absorbance of each well at 490nm. The cell survival rate is calculated using the following formula:

[0045] Cell viability (%) = (A sample / A blank) × 100%.

[0046] To further demonstrate that the nanoparticles have efficient in vitro cytotoxicity, the Calcein-AM / PI live cell / dead cell double staining kit was used for cell staining.

[0047] The curcumin / polyethylene glycol-grafted polyglutamic acid / iron-coordinated dissociable nanoparticle solution of Example 1 was freeze-dried and then dissolved in deionized water to obtain nanoparticle aqueous solutions of different concentrations (0, 5, 10, 15, 20, 25 and 50 μg mL -1 ), the results showed that different concentrations of nanoparticles in aqueous solution (0, 5, 10, 15, 20, 25 and 50 μg mL -1 ) and 4T1 cells for 24 h, the cell survival rate showed no significant difference ( Figure 2 In contrast, the nanoparticles in aqueous solution with different concentrations (0, 5, 10, 15, 20, 25 and 50 μg mL -1 ) were co-incubated with 808 nm laser (1 W cm -2 After irradiation for 5 min, the cell survival rate decreased with the increase of nanoparticle concentration, and the photothermal effect increased, which confirmed the potential of the nanoparticles as photothermal agents. The photothermal effect produced under laser irradiation can significantly kill tumor cells ( Figure 2 D and E).

[0048] 3. Biodistribution in vivo

[0049] Tumor-bearing mice were injected with nanoparticle solution (100 μL, 500 μg mL -1 ) at different time points (0, 6, 12, 24 and 48 h) after inoculation, the main organs (heart, liver, spleen, lung and kidney) and tumors were collected, weighed and nitrated, and the iron content was determined by ICP-MS for biodistribution analysis.

[0050] like Figure 2 As shown in Figure F, the nanoparticles gradually accumulated in the tumor site, and the accumulation reached a peak 24 hours after injection. Therefore, the nanoparticles have a longer blood circulation time and a larger tumor accumulation, which is beneficial for their in vivo treatment.

[0051] IV. In vivo photothermal performance evaluation

[0052] Considering that the in vivo biodistribution results showed that the nanoparticles accumulated in the tumor reached the maximum value 24 hours after tail vein injection, and the nanoparticles had excellent photothermal properties, the nanoparticles were further studied for their in vivo photothermal imaging performance. 3 The nanoparticle solution (100 μL, 500 μg mL -1 At 24h, 808nm laser (1W·cm -2 During the laser irradiation process, a thermal imager was used to take pictures of the mice and monitor the temperature of the tumor site in real time.

[0053] The in vivo photothermal effect of nanoparticles was measured using a thermal imager. After 24 hours of intravenous injection, the tumor site of the mouse was irradiated with 808nm laser, and the temperature rose rapidly from 35.9℃ to 54.1℃ within 5 minutes ( Figure 2 The results show that the nanoparticles have great potential for application in photothermal therapy and thermal imaging.

[0054] 5. In vivo photothermal therapy

[0055] The in vivo photothermal experiment used a 4T1 tumor model and Balb / C mice weighing about 20 g. 4T1 cells in the logarithmic growth phase were obtained, digested with trypsin, and suspended in PBS. 1×10 cells were added to each mouse. 6 The cells were inoculated at a density of 100 μg / cm2 into the right hind leg of the mouse, and the tumor was grown to 80 mm in size. 3 The nanoparticle solution obtained in Example 1 was injected into mice through the tail vein. After 24 hours, laser irradiation (808 nm, 1 W·cm -2 , 5min) and DFO injection (injection volume 10mg·kg -1 ). Two days after DFO injection, mice were sacrificed and tumors were collected for hematoxylin-eosin (H&E) staining. The length (a) and width (b) of the tumor and the weight of the mice were measured every other day, and the volume of the tumor was calculated according to the following formula. The whole experiment was followed for 22 days.

[0056] Tumor volume: V = a 2 b / 2

[0057] like Figure 3 As shown in A, when the tumor volume reaches about 80 mm 3The tumor-bearing mice were randomly divided into 5 groups: PBS, PBS+Laser, FeCNPs, FeCNPs+Laser and FeCNPs+Laser+DFO. The PBS group was injected with 100 μL PBS solution via the tail vein at 0 h. The PBS+Laser group was injected with 100 μL PBS solution via the tail vein at 0 h, and then irradiated with light (808 nm, 1 W·cm -2 , 5min); FeCNPs group: at 0h, mice were injected with FeCNPs solution (100μL, 500μg·mL -1 ); FeCNPs+Laser group: at 0h, mice were injected with FeCNPs solution (100μL, 500μg·mL -1 ), and at 24 h, the mice were irradiated with light (808 nm, 1 W·cm -2 , 5min); FeCNPs+Laser+DFO group: at 0h, mice were injected with FeCNPs solution (100μL, 500μg·mL -1 ), and at 24 h, the mice were irradiated with light (808 nm, 1 W·cm -2 , 5 min) and tail vein injection of DFO solution (10 mg kg -1 ). Compared with the rapid tumor growth in the PBS group, the tumor volume growth curves of the PBS+Laser group and the mice injected with FeCNPs showed similar tumor growth trends. However, after FeCNPs injection and light treatment (FeCNPs+Laser group), the tumor growth of tumor-bearing mice was significantly delayed, showing excellent tumor inhibition effect. The tumor inhibition results of the FeCNPs+Laser+DFO group showed that the thermal effect of photothermal therapy and the synergistic effect of tumor-specific chemotherapy can achieve complete tumor clearance ( Figure 3 Middle B). The images and weight of mouse tumors also confirmed the anti-tumor advantage of the FeCNPs+Laser+DFO group ( Figure 3 It is noteworthy that no significant changes in the body weight of mice were found during the treatment period ( Figure 3 E). Hematoxylin-eosin (H&E) staining of tumor tissue sections showed that after FeCNPs+Laser treatment, a large amount of nuclear dissolution occurred in the tumor tissue, indicating that the nanoparticle-mediated photothermal therapy can induce apoptosis and necrosis of tumor cells. More tumor cell apoptosis and necrosis occurred in the FeCNPs+Laser+DFO group ( Figure 3 Middle F). After treatment, the internal organs of mice in each group showed no abnormalities, indicating that the nanoparticles have good biocompatibility and do not cause systemic toxicity ( Figure 4 ).

[0058] VI. In vivo metabolism studies

[0059] Since nanoparticles can be disassembled by DFO, their metabolic behavior in vivo after dissociation was studied. At 0 h, tumor-bearing mice were injected with nanoparticle solution (100 μL, 500 μg mL -1 ); at 24 h, DFO (10 mg kg -1 At different time points (30, 48, 72, 96 and 168 h), the liver, kidney, feces and urine of mice were collected, weighed, nitrated, and the iron content was determined by ICP-MS for in vivo metabolism study.

[0060] like Figure 5 As shown in Figure A, mice were injected with nanoparticle solution at 0h and DFO solution at 24h, and then the liver, kidney, feces and urine of mice were collected and processed for ICP-MS testing. The results showed that at 30h (i.e. 6h after DFO treatment of tumor-bearing mice injected with FeCNPs), the iron content in the liver of mice decreased significantly ( Figure 5 B), the iron content in the kidneys increased significantly ( Figure 5 C). This indicates that the introduction of DFO can effectively dissociate nanoparticles in the liver, thereby reducing the retention time of nanoparticles in the liver. In addition, the iron content in feces and urine was tracked. Figure 5 As shown in Figure D, higher levels of iron were detected in the feces of mice not injected with DFO, proving that the nanoparticles were mainly excreted into the feces through liver clearance. However, the iron content in the urine of mice injected with DFO was significantly higher than that of mice not injected with DFO, indicating that the assembled FeCNPs were mainly cleared into the urine through the kidneys and excreted from the body ( Figure 5 The above results confirm that the dynamic disassembly strategy triggered by DFO significantly changes the clearance mode of nanoparticles in the body, accelerates their clearance process, and can effectively avoid potential harm to the liver.

[0061] In summary, FeCNPs is a safe photothermal agent that does not cause systemic toxicity; moreover, it can achieve excellent anti-tumor effects under laser irradiation. However, after photothermal therapy (FeCNPs+Laser), the tumor growth curve still maintains an upward trend, which means that the tumor may recur over time. Therefore, it is very necessary to adopt a combined treatment strategy to overcome this problem. In the FeCNPs+Laser+DFO treatment group, curcumin released during the dissociation of FeCNPs has excellent chemotherapeutic properties, and is expected to synergize with photothermal therapy to achieve efficient tumor clearance.

[0062] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.

Claims

1. A method for preparing dissociable nanoparticles based on curcumin iron coordination, characterized in that: The following steps are involved: The soluble iron salt, polyethylene glycol-grafted polyglutamic acid and water are evenly mixed, and then a curcumin ethanol solution is added, and then the curcumin iron-coordinated dissociable nanoparticles are prepared after stirring, impurity removal, centrifugation and ultrasound.

2. The method for preparing dissociable nanoparticles based on curcumin iron coordination according to claim 1, characterized in that: The soluble iron salt is ferric chloride.

3. The method for preparing dissociable nanoparticles based on curcumin iron coordination according to claim 1, characterized in that: The preparation steps of the polyethylene glycol grafted polyglutamic acid include: first, preparing poly-L-glutamic acid by ring-opening polymerization of BLG-NCA and then removing benzyl protection, and then preparing polyethylene glycol grafted polyglutamic acid by Steglich esterification reaction of poly-L-glutamic acid and polyethylene glycol monomethyl ether; wherein the molecular weight of polyethylene glycol monomethyl ether is 1000-10000Da, the molecular weight of poly-L-glutamic acid is 10000-50000Da, and the mass ratio of polyethylene glycol monomethyl ether to poly-L-glutamic acid is (1-10):

1.

4. The method for preparing dissociable nanoparticles based on curcumin iron coordination according to claim 1, characterized in that: The usage ratio of the soluble iron salt, the polyethylene glycol-grafted polyglutamic acid and the curcumin is 1.48 mmol:457.6 mg:200 mg.

5. The method for preparing dissociable nanoparticles based on curcumin iron coordination according to claim 1, characterized in that: The concentration of the curcumin ethanol solution is 10 mg mL -1 The curcumin ethanol solution was added dropwise at a rate of 0.5 to 1 mL min -1 .

6. The method for preparing dissociable nanoparticles based on curcumin iron coordination according to claim 1, characterized in that: The stirring time is 4 to 24 hours; the impurity removal method is dialysis; the centrifugal speed is 6000 to 10000 rpm; and the ultrasonic time is 5 to 30 minutes.

7. Dissociable nanoparticles based on curcumin iron coordination obtained according to the preparation method of dissociable nanoparticles based on curcumin iron coordination according to any one of claims 1 to 6.

8. Use of the dissociable nanoparticles based on curcumin iron coordination according to claim 7 in the preparation of photothermal therapy drugs.

9. The method for dissociating the dissociable nanoparticles based on curcumin iron coordination according to claim 7, characterized in that: The substance used for the dissociation is deferoxamine mesylate.

10. Use of the dissociable nanoparticles based on curcumin iron coordination according to claim 7 and deferoxamine mesylate in the preparation of a combined photothermal therapy and chemotherapy drug.

Citation Information

Cited By

  • Nano-micelle responding to inflammation microenvironment as well as preparation method and application of nano-micelle

    CN119732906A